116
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells

, , , , , , , , , & show all
Pages 753-764 | Received 08 Sep 2010, Accepted 25 Dec 2010, Published online: 11 Feb 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Mahboubeh Yazdanifar, Narges Mashkour & Alice Bertaina. (2020) Making a case for using γδ T cells against SARS-CoV-2. Critical Reviews in Microbiology 46:6, pages 689-702.
Read now
Dang Wu, Pin Wu, Xianguo Wu, Jun Ye, Zhen Wang, Shuai Zhao, Chao Ni, Guoming Hu, Jinghong Xu, Yuehua Han, Ting Zhang, Fuming Qiu, Jun Yan & Jian Huang. (2015) Ex vivo expanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer. OncoImmunology 4:3.
Read now
Dieter Kabelitz, Shirin Kalyan, Hans-Heinrich Oberg & Daniela Wesch. (2013) Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity. OncoImmunology 2:3.
Read now
Andrea Knight, Stephen Mackinnon & Mark W. Lowdell. (2012) Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells. Cytotherapy 14:9, pages 1110-1118.
Read now
Gabrielle M. Siegers. (2012) Anti-leukemia activity of human gamma delta T cells. OncoImmunology 1:2, pages 237-239.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.